Vassallo, Chiara, Beatrice Canali, Francesca Fiorentino, Paolo Morelli, Silvia Ripoli, and Laura Fioravanti. “Brentuximab Vedotin + AVD in CHL: Cost Impact on Adverse Events, Toxicity, Second Malignancies, End-of-Life and Subsequent Lines of Therapy in Italy”. AboutOpen 10, no. 1 (October 2, 2023): 103–109. Accessed July 3, 2024. https://journals.aboutscience.eu/index.php/aboutopen/article/view/2609.